Emergency Contraception in Estonia

Euromonitor International, March 2012, Pages: 17

Emergency contraception current value sales increased by 5% with value sales reaching EUR0.5 million in 2011. Emergency contraception posted a very strong performance after the economic crisis ended and consumer purchasing power rose for the first time after eleven consecutive quarters of decline: some women consider these products to be essential. Escapelle 1.5mg and Postinor-2 were the only two products available in 2011.

The Emergency Contraception in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Emergency Contraception market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

EMERGENCY CONTRACEPTION IN ESTONIA
Euromonitor International
March 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Emergency Contraception: Value 2006-2011
Table 2 Sales of Emergency Contraception: % Value Growth 2006-2011
Table 3 Emergency Contraception Company Shares 2007-2011
Table 4 Emergency Contraception Brand Shares 2008-2011
Table 5 Forecast Sales of Emergency Contraception: Value 2011-2016
Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016
Executive Summary
Economy Shows Strong Signs of Recovery and Sales Increase
Health Organisations Try To Raise Consumer Awareness
International Players Strengthen Their Positions
Chemists/pharmacies Hold the Leading Position
Value Sales Expected To Record Steady Growth Over Forecast Period
Key Trends and Developments
Economic Conditions Help Drive Consumer Health Sales
Allowing OTC Medicines for Sale in Other Retailing Channels
Estonian Population Is Ageing
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2009-2011
Sources
Summary 2 Research Sources

Customers who bought this item also bought

• Emergency Contraception in France
• Emergency Contraception in the Netherlands
• Emergency Contraception in Nigeria
• Consumer Health in India
• Consumer Health in Uruguay
• Consumer Health in Lithuania
• Consumer Health in China
• Consumer Health in Sweden
• Consumer Health in Finland
• Consumer Health in Latvia